TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)

$5.09 -0.3 (-5.5659%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) News Sources

TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer

17-11-2025

yahoo.com

TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCode's Phase 1 trial

11-12-2025

yahoo.com

TransCode Therapeutics Expands Leadership with Appointment of Jack E. Stover to Board of Directors

22-12-2025

yahoo.com

TransCode Therapeutics Announces Publication of Preclinical Data Supporting Therapeutic Potential of TTX-MC138 in Glioblastoma

06-01-2026

yahoo.com

TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138

05-02-2026

yahoo.com

TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development

23-02-2026

yahoo.com

TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients

03-03-2026

yahoo.com

CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development

10-03-2026

yahoo.com

TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028

07-04-2026

yahoo.com

TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University

27-04-2026

yahoo.com

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) Sentiment Trend

0 25 50 75 100 83 86 69 61 65 70 89 62 78 60 17-11-2025 11-12-2025 22-12-2025 06-01-2026 05-02-2026 23-02-2026 03-03-2026 10-03-2026 07-04-2026 27-04-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) FAQs

toggle

What is the current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?

The current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is $5.09.


toggle

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) absolute price change since previous trading day?

The absolute price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is $-0.3.


toggle

TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) percentage price change since previous trading day?

The percentage price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is -5.5659%.


toggle

What is the most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?

The most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?

The most recent sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is .


SEC-8K** Filing Available For TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.